`Indian pharma must balance generics with innovation’

NEW DELHI: India’s pharmaceutical industry must focus on both generics and innovative products, as well as develop products specially tailored for the country’s patient needs. Domestic companies particularly smaller to mid-sized players can carve out a strong role in rare diseases and niche patient segments, where agility and specialised research can drive meaningful breakthroughs, pharma…

Read More

Paytm ownership shift: Domestic investors cross 50% stake; firm turns majority Indian-controlled

One 97 Communications Ltd, which operates the Paytm brand, has become a majority Indian-owned and controlled company after domestic investors raised their stake to 50.3% as of March-end 2026, PTI reported.The shift marks a structural change in ownership for the fintech firm, with domestic shareholding rising steadily in recent quarters, reflecting growing investor confidence.Domestic institutional…

Read More

India’s bankruptcy law gets its new overhaul: What the IBC Amendment Act, 2026 changes and why it matters

NEW DELHI: On April 6, 2026, the President of India gave assent to the Insolvency and Bankruptcy Code (Amendment) Act, 2026–No. 6 of 2026–and the legislation was published in the Gazette of India. A decade after the original IBC was enacted in 2016, Parliament has approved what practitioners call the most comprehensive rewrite of the…

Read More

US markets today (April 14, 2026): Dow, S&P 500, Nasdaq rise on Middle East de-escalation hopes; earnings in focus

Wall Street extended its gains on Tuesday, with investors stepping back into equities amid fresh signals that diplomatic efforts could ease tensions in the Middle East, even as corporate earnings remained in sharp focus.The Dow Jones Industrial Average rose 227.05 points, or 0.47%, to 48,445.30, while the S&P 500 gained 32.09 points, or 0.47%, to…

Read More